Company Analysis

enVVeno Medical Corporation (NVNO)

Nasdaq: NVNO · Surgical & Medical Instruments & Apparatus · Irvine, CA · filing with the SEC since 2015
Grade3.6
◀ Past 1.8● Present 4.4▶ Future 4.2
3 est.

Who runs enVVeno Medical Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Berman Robert Andrew
Chief Executive Officer. First filing May 2018, latest Dec 18, 2025, 7 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
18 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Berman Robert AndrewChief Executive OfficerMay 2018Dec 18, 2025none
Alavi HamedChief Technology OfficerJan 2023Dec 18, 2025none
Glickman Marc H.SVP & Chief Medical OfficerMay 2018Dec 18, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Duhay FrancisdirectorNov 2018Sep 14, 20264 · $0.00
Gray RobertdirectorSep 2019Dec 15, 2025none
Jenusaitis MatthewdirectorJul 2020Dec 15, 2025none
Shrivastava SanjaydirectorOct 2018Dec 15, 2025none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NVNO · research, not advice